182 related articles for article (PubMed ID: 34239347)
1. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
Bian R; Dang W; Song X; Liu L; Jiang C; Yang Y; Li Y; Li L; Li X; Hu Y; Bao R; Liu Y
Int J Biol Sci; 2021; 17(9):2167-2180. PubMed ID: 34239347
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
3. miR-22 suppresses DNA ligase III addiction in multiple myeloma.
Caracciolo D; Di Martino MT; Amodio N; Morelli E; Montesano M; Botta C; Scionti F; Talarico D; Altomare E; Gallo Cantafio ME; Zuccalà V; Maltese L; Todoerti K; Rossi M; Arbitrio M; Neri A; Tagliaferri P; Tassone P
Leukemia; 2019 Feb; 33(2):487-498. PubMed ID: 30120376
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
[TBL] [Abstract][Full Text] [Related]
5. Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer.
Wang C; Wang W; Liu Y; Yong M; Yang Y; Zhou H
Cancer Sci; 2018 Jan; 109(1):84-93. PubMed ID: 29095547
[TBL] [Abstract][Full Text] [Related]
6. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
7. Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma.
Yin C; Toiyama Y; Okugawa Y; Shigemori T; Yamamoto A; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Yoshiyama S; Ohi M; Araki T; Yao L; Kusunoki M
Oncology; 2019; 97(3):155-163. PubMed ID: 31216559
[TBL] [Abstract][Full Text] [Related]
8. RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
Hazar-Rethinam M; de Long LM; Gannon OM; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Saenz-Ponce N; Dantzic DD; Simpson F; Saunders NA
Mol Cancer Ther; 2015 Aug; 14(8):1939-50. PubMed ID: 26018753
[TBL] [Abstract][Full Text] [Related]
9. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
[TBL] [Abstract][Full Text] [Related]
10. Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
Caracciolo D; Juli G; Riillo C; Coricello A; Vasile F; Pollastri S; Rocca R; Scionti F; Polerà N; Grillone K; Arbitrio M; Staropoli N; Caparello B; Britti D; Loprete G; Costa G; Di Martino MT; Alcaro S; Tagliaferri P; Tassone P
J Transl Med; 2022 Oct; 20(1):482. PubMed ID: 36273153
[TBL] [Abstract][Full Text] [Related]
11. RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis.
Ren K; Zhou D; Wang M; Li E; Hou C; Su Y; Zou Q; Zhou P; Liu X
Exp Cell Res; 2021 Mar; 400(1):112493. PubMed ID: 33485843
[TBL] [Abstract][Full Text] [Related]
12. RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex.
Jacquemet G; Green DM; Bridgewater RE; von Kriegsheim A; Humphries MJ; Norman JC; Caswell PT
J Cell Biol; 2013 Sep; 202(6):917-35. PubMed ID: 24019536
[TBL] [Abstract][Full Text] [Related]
13. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway.
Jia J; Li S; Gong W; Ding J; Fang C; Quan Z
Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977
[TBL] [Abstract][Full Text] [Related]
14. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
15. RacGAP1 ameliorates acute kidney injury by promoting proliferation and suppressing apoptosis of renal tubular cells.
Zhou W; Zhao S; Xu S; Sun Z; Liang Y; Ding X
Biochem Biophys Res Commun; 2020 Jun; 527(3):624-630. PubMed ID: 32423815
[TBL] [Abstract][Full Text] [Related]
16. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
19. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
Doksani Y; de Lange T
Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
